M. Soulié

Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study

Christian Pfister, Gwénaëlle Gravis, Aude Fléchon et al. · The Lancet Oncology · 2023 · 77 citations

Survival Endpoints, Surgical Oncology, Urology +7

Pathologic Findings in Radical Prostatectomy Specimens From Patients Eligible for Active Surveillance With Highly Selective Criteria: A Multicenter Study

Jean‐Baptiste Beauval, Guillaume Ploussard, M. Soulié et al. · Urology · 2012 · 67 citations

Urology, Surgical Oncology, Cancer Screening +8

Patients’ self-assessment versus investigators’ evaluation in a phase III trial in non-castrate metastatic prostate cancer (GETUG-AFU 15)

Gwénaëlle Gravis, Patricia Marino, Florence Joly et al. · European Journal of Cancer · 2014 · 65 citations

Urology, Meta-analysis, Medicine +11

The effect of gender and age on kidney cancer survival: Younger age is an independent prognostic factor in women with renal cell carcinoma

Edward N. Rampersaud, Tobias Klatte, Geoffrey D. Bass et al. · Urologic Oncology Seminars and Original Investigations · 2013 · 59 citations

Urology, Genitourinary Cancer, Longevity +8

Predictive Factors of Oncologic Outcomes in Patients Who do not Achieve Undetectable Prostate Specific Antigen after Radical Prostatectomy

Guillaume Ploussard, Frédéric Staerman, Jean Pierrevelcin et al. · The Journal of Urology · 2013 · 52 citations